We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ValiRx PLC 10 December 2024 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER ARTICLE 7 OF THE MARKET ABUSE...
ValiRx PLC 10 December 2024 ValiRx plc ("ValiRx" or the "Company") Posting of Circular and Notice of General Meeting London, UK - ValiRx Plc (AIM: VAL), a life science company focusing...
ValiRx PLC 09 December 2024 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN (THE "ANNOUNCEMENT") IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR...
ValiRx PLC 22 November 2024 ValiRx plc ("ValiRx" or the "Company") Inaphaea award of HEIF Funding and PhD sponsorship London, UK - ValiRx Plc (AIM: VAL), a life science company...
x, England-based life sciences company - Says subsidiary ValiSeek Ltd has granted a six-month extension to Ambrose Hea ...
ValiRx PLC 20 November 2024 20 November 2024 ValiRx PLC ("ValiRx" or the "Company") Update on proposed sub-license of VAL401 London, UK - ValiRx Plc (AIM: VAL), a life science company...
ValiRX PLC announced on Tuesday it will provide more cancer cell detection materials to UK biotech firm Amply Discove ...
ValiRx PLC 19 November 2024 19 November 2024 ValiRx PLC ("ValiRx" or the "Company") Contract Award London, UK - ValiRx Plc (AIM: VAL), a life science company focusing on early-stage...
ield Heath, England-based life sciences company focused on early-stage cancer therapeutics and women's health - Says s ...
ValiRx PLC 18 November 2024 18 November 2024 ValiRx PLC ("ValiRx" or the "Company") First Sale of New Product Line London, UK - ValiRx Plc (AIM: VAL), a life science company focusing...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.725 | -48.3333333333 | 1.5 | 1.5 | 0.75 | 9791539 | 0.78243787 | DE |
4 | -0.65 | -45.6140350877 | 1.425 | 1.85 | 0.75 | 2651195 | 0.84696083 | DE |
12 | -0.875 | -53.0303030303 | 1.65 | 2.3 | 0.75 | 1544651 | 1.25916703 | DE |
26 | -1.925 | -71.2962962963 | 2.7 | 3.3 | 0.75 | 1012602 | 1.60915962 | DE |
52 | -6.975 | -90 | 7.75 | 7.75 | 0.75 | 1168258 | 2.8388735 | DE |
156 | -32.975 | -97.7037037037 | 33.75 | 44.25 | 0.75 | 917834 | 9.76463272 | DE |
260 | -4.025 | -83.8541666667 | 4.8 | 67.5 | 0.75 | 2963523 | 9.84929602 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions